MS RESEARCH AUSTRALIA BRAIN BANK NEWS
Three MS treatments will be considered for inclusion on the PBS at a PBAC meeting in March – nabiximols (Sativex), siponimod (Mayzent), ozanimod (Zeposia).
MS Research Australia has funded six new MS studies totalling almost $150,000 in the first round of incubator […]
Associate Professor Kaylene Young and Professor Bruce Taylor are working towards new discoveries that may provide treatments to […]
The first ever treatment for secondary progressive MS, a form of MS that can follow on from relapsing remitting MS, has been approved in Australia.
Although there has been quite a bit of research into the contribution of genes to the risk of […]
Myelin oligodendrocyte glycoprotein (MOG) antibody is associated with many demyelinating conditions, but it has not be characterised in-depth. […]
A large international study led by an Australian researcher has identified risk factors that may contribute to conversion to secondary progressive MS.